Platelet Membrane-Coated HGF-PLGA Nanoparticles Promote Therapeutic Angiogenesis and Tissue Perfusion Recovery in Ischemic Hindlimbs
Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. I...
Saved in:
Published in | ACS applied bio materials Vol. 8; no. 1; pp. 399 - 409 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
20.01.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. In this study, we successfully developed and characterized platelet membrane-coated HGF-poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs). These nanoparticles demonstrated enhanced capabilities to promote endothelial cell (EC) proliferation, migration, and tube formation in vitro. Additionally, their efficacy in improving tissue perfusion and promoting angiogenesis was confirmed in a hindlimb ischemia rat model. Our findings suggest that platelet membrane-coated HGF-PLGA-NPs could serve as a promising therapeutic approach for enhancing angiogenesis and restoring tissue perfusion in ischemic conditions. |
---|---|
AbstractList | Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. In this study, we successfully developed and characterized platelet membrane-coated HGF-poly(lactic-
-glycolic acid) (PLGA) nanoparticles (NPs). These nanoparticles demonstrated enhanced capabilities to promote endothelial cell (EC) proliferation, migration, and tube formation in vitro. Additionally, their efficacy in improving tissue perfusion and promoting angiogenesis was confirmed in a hindlimb ischemia rat model. Our findings suggest that platelet membrane-coated HGF-PLGA-NPs could serve as a promising therapeutic approach for enhancing angiogenesis and restoring tissue perfusion in ischemic conditions. Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. In this study, we successfully developed and characterized platelet membrane-coated HGF-poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs). These nanoparticles demonstrated enhanced capabilities to promote endothelial cell (EC) proliferation, migration, and tube formation in vitro. Additionally, their efficacy in improving tissue perfusion and promoting angiogenesis was confirmed in a hindlimb ischemia rat model. Our findings suggest that platelet membrane-coated HGF-PLGA-NPs could serve as a promising therapeutic approach for enhancing angiogenesis and restoring tissue perfusion in ischemic conditions.Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. In this study, we successfully developed and characterized platelet membrane-coated HGF-poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs). These nanoparticles demonstrated enhanced capabilities to promote endothelial cell (EC) proliferation, migration, and tube formation in vitro. Additionally, their efficacy in improving tissue perfusion and promoting angiogenesis was confirmed in a hindlimb ischemia rat model. Our findings suggest that platelet membrane-coated HGF-PLGA-NPs could serve as a promising therapeutic approach for enhancing angiogenesis and restoring tissue perfusion in ischemic conditions. Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. In this study, we successfully developed and characterized platelet membrane-coated HGF-poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs). These nanoparticles demonstrated enhanced capabilities to promote endothelial cell (EC) proliferation, migration, and tube formation in vitro. Additionally, their efficacy in improving tissue perfusion and promoting angiogenesis was confirmed in a hindlimb ischemia rat model. Our findings suggest that platelet membrane-coated HGF-PLGA-NPs could serve as a promising therapeutic approach for enhancing angiogenesis and restoring tissue perfusion in ischemic conditions. |
Author | Wang, Peng Li, Fengshi Rong, Zhihua Liu, ChangWei Chen, Tianqi Zhong, Qing Di, Xiao Li, Zongshu Ni, Leng Wang, Wenjing Lian, Wenzhuo Sun, Guoqiang |
AuthorAffiliation | Department of Vascular Surgery Biomedical Engineering Facility of National Infrastructures for Translational Medicine, Institute of Clinical Medicine Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College Laboratory Animal Research Facility, National Infrastructures for Translational Medicine, Institute of Clinical Medicine Department of Information Center Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College |
AuthorAffiliation_xml | – name: Laboratory Animal Research Facility, National Infrastructures for Translational Medicine, Institute of Clinical Medicine – name: Biomedical Engineering Facility of National Infrastructures for Translational Medicine, Institute of Clinical Medicine – name: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College – name: Department of Information Center – name: Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College – name: Department of Vascular Surgery |
Author_xml | – sequence: 1 givenname: Peng orcidid: 0000-0003-4176-2565 surname: Wang fullname: Wang, Peng organization: Department of Vascular Surgery – sequence: 2 givenname: Xiao surname: Di fullname: Di, Xiao organization: Department of Vascular Surgery – sequence: 3 givenname: Fengshi surname: Li fullname: Li, Fengshi organization: Department of Vascular Surgery – sequence: 4 givenname: Zhihua surname: Rong fullname: Rong, Zhihua organization: Department of Vascular Surgery – sequence: 5 givenname: Wenzhuo surname: Lian fullname: Lian, Wenzhuo organization: Department of Vascular Surgery – sequence: 6 givenname: Zongshu surname: Li fullname: Li, Zongshu organization: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College – sequence: 7 givenname: Tianqi surname: Chen fullname: Chen, Tianqi organization: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College – sequence: 8 givenname: Wenjing surname: Wang fullname: Wang, Wenjing organization: Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College – sequence: 9 givenname: Qing surname: Zhong fullname: Zhong, Qing organization: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College – sequence: 10 givenname: Guoqiang surname: Sun fullname: Sun, Guoqiang organization: Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College – sequence: 11 givenname: Leng surname: Ni fullname: Ni, Leng email: pumchnileng@gmail.com organization: Department of Vascular Surgery – sequence: 12 givenname: ChangWei surname: Liu fullname: Liu, ChangWei email: liucw@vip.sina.com organization: Department of Vascular Surgery |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39723905$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kUtrGzEUhUVJaR7NtsuiZSmMq-c8lsYkdsBtTXHXQiPdSRRmJFfSFLLvD6-CHSiFrO7l8J0L95xLdOaDB4Q-ULKghNEv2iTdTwthCOUNf4MumGzqqhaMnf2zn6PrlB4JIYwQTtvuHTrnXcN4R-QF-rMbdYYRMv4KUx-1h2oVimLxZn1b7bbrJf6mfTjomJ0ZIeFdDFPIgPcPEPUB5iLjpb934R48JJew9hbvXUoz4B3EYU4uePwDTPgN8Qk7j--SeYCp2DbO29FNfXqP3g56THB9mlfo5-3NfrWptt_Xd6vlttKck1xJ1ja1ZmxoW2EJsdRaWgPrapCSmaGk0AvCGUiwnSSNFd3QakGGoe-p6YzmV-jT8e4hhl8zpKwmlwyMY3k7zElxKjopiJS0oB9P6NxPYNUhuknHJ_WSXAHEETAxpBRhUMZlncuzOWo3KkrUc0fq2JE6dVRsi_9sL5dfNXw-GoquHsMcfUnoNfgvYG6jqw |
CitedBy_id | crossref_primary_10_3390_ijms26062386 |
Cites_doi | 10.1002/adma.201706759 10.1038/gt.2010.101 10.1016/j.ahj.2022.08.007 10.1016/j.biomaterials.2017.02.041 10.1039/D0NR08492A 10.1038/mt.2008.33 10.1016/S0140-6736(96)03361-2 10.1002/sstr.202000018 10.1371/journal.pone.0038776 10.1186/s13073-023-01250-y 10.1172/JCI113334 10.1093/oxfordjournals.jbchem.a021283 10.1007/s13346-024-01577-y 10.1016/j.jconrel.2020.08.030 10.1161/01.ATV.0000048701.86621.D0 10.1016/j.nano.2018.08.002 10.1111/j.1440-1746.2010.06549.x 10.1016/j.vph.2012.02.002 10.2183/pjab.86.588 10.3389/fimmu.2020.02135 10.1016/j.jvs.2019.02.016 10.1093/eurheartj/ehx095 10.1089/hum.2017.217 10.1016/j.jacc.2018.03.008 10.2147/IJN.S452989 10.1039/D0NR08440A 10.1021/acsnano.7b07720 10.2147/IJN.S214727 10.3389/fendo.2020.00062 10.1186/1479-5876-9-55 10.1021/acsami.3c18464 10.1038/nature15373 10.2147/IJN.S423186 10.1016/j.isci.2022.105147 10.1016/j.apsb.2017.12.002 |
ContentType | Journal Article |
Copyright | 2024 The Authors. Published by American Chemical Society |
Copyright_xml | – notice: 2024 The Authors. Published by American Chemical Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1021/acsabm.4c01373 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 2576-6422 |
EndPage | 409 |
ExternalDocumentID | 39723905 10_1021_acsabm_4c01373 c697706203 |
Genre | Journal Article |
GroupedDBID | 53G ABQRX ABUCX ACS AHGAQ ALMA_UNASSIGNED_HOLDINGS BAANH CUPRZ EBS GGK VF5 VG9 AAYXX ABBLG ABJNI ABLBI CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-a330t-52876a22f884d00d1dd16e296e552cfc01b4032e5ed9507d49f8a40ffbb1c9ca3 |
IEDL.DBID | ACS |
ISSN | 2576-6422 |
IngestDate | Fri Jul 11 04:26:20 EDT 2025 Mon Jul 21 05:47:37 EDT 2025 Sun Jul 06 05:03:42 EDT 2025 Thu Apr 24 22:56:24 EDT 2025 Tue Jan 21 04:03:37 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | therapeutic angiogenesis peripheral artery disease drug delivery chronic limb-threatening ischemia hepatocyte growth factor |
Language | English |
License | https://doi.org/10.15223/policy-029 https://creativecommons.org/licenses/by-nc-nd/4.0 https://doi.org/10.15223/policy-045 https://doi.org/10.15223/policy-037 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a330t-52876a22f884d00d1dd16e296e552cfc01b4032e5ed9507d49f8a40ffbb1c9ca3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4176-2565 |
PMID | 39723905 |
PQID | 3149540551 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_3149540551 pubmed_primary_39723905 crossref_citationtrail_10_1021_acsabm_4c01373 crossref_primary_10_1021_acsabm_4c01373 acs_journals_10_1021_acsabm_4c01373 |
PublicationCentury | 2000 |
PublicationDate | 2025-01-20 |
PublicationDateYYYYMMDD | 2025-01-20 |
PublicationDate_xml | – month: 01 year: 2025 text: 2025-01-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | ACS applied bio materials |
PublicationTitleAlternate | ACS Appl. Bio Mater |
PublicationYear | 2025 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | ref9/cit9 ref6/cit6 ref3/cit3 ref27/cit27 ref18/cit18 ref11/cit11 ref25/cit25 ref16/cit16 ref29/cit29 ref32/cit32 ref23/cit23 ref14/cit14 ref8/cit8 ref5/cit5 ref31/cit31 ref2/cit2 ref34/cit34 ref28/cit28 ref20/cit20 ref17/cit17 ref10/cit10 ref26/cit26 ref35/cit35 ref19/cit19 ref21/cit21 ref12/cit12 ref15/cit15 ref22/cit22 ref13/cit13 ref33/cit33 ref4/cit4 ref30/cit30 ref1/cit1 ref24/cit24 ref7/cit7 |
References_xml | – ident: ref16/cit16 doi: 10.1002/adma.201706759 – ident: ref5/cit5 doi: 10.1038/gt.2010.101 – ident: ref6/cit6 doi: 10.1016/j.ahj.2022.08.007 – ident: ref17/cit17 doi: 10.1016/j.biomaterials.2017.02.041 – ident: ref18/cit18 doi: 10.1039/D0NR08492A – ident: ref7/cit7 doi: 10.1038/mt.2008.33 – ident: ref4/cit4 doi: 10.1016/S0140-6736(96)03361-2 – ident: ref20/cit20 doi: 10.1002/sstr.202000018 – ident: ref35/cit35 doi: 10.1371/journal.pone.0038776 – ident: ref28/cit28 doi: 10.1186/s13073-023-01250-y – ident: ref32/cit32 doi: 10.1172/JCI113334 – ident: ref31/cit31 doi: 10.1093/oxfordjournals.jbchem.a021283 – ident: ref13/cit13 doi: 10.1007/s13346-024-01577-y – ident: ref26/cit26 doi: 10.1016/j.jconrel.2020.08.030 – ident: ref9/cit9 doi: 10.1161/01.ATV.0000048701.86621.D0 – ident: ref34/cit34 doi: 10.1016/j.nano.2018.08.002 – ident: ref33/cit33 doi: 10.1111/j.1440-1746.2010.06549.x – ident: ref12/cit12 doi: 10.1016/j.vph.2012.02.002 – ident: ref11/cit11 doi: 10.2183/pjab.86.588 – ident: ref10/cit10 doi: 10.3389/fimmu.2020.02135 – ident: ref2/cit2 doi: 10.1016/j.jvs.2019.02.016 – ident: ref1/cit1 doi: 10.1093/eurheartj/ehx095 – ident: ref8/cit8 doi: 10.1089/hum.2017.217 – ident: ref3/cit3 doi: 10.1016/j.jacc.2018.03.008 – ident: ref15/cit15 doi: 10.2147/IJN.S452989 – ident: ref19/cit19 doi: 10.1039/D0NR08440A – ident: ref25/cit25 doi: 10.1021/acsnano.7b07720 – ident: ref22/cit22 doi: 10.2147/IJN.S214727 – ident: ref29/cit29 doi: 10.3389/fendo.2020.00062 – ident: ref30/cit30 doi: 10.1186/1479-5876-9-55 – ident: ref14/cit14 doi: 10.1021/acsami.3c18464 – ident: ref21/cit21 doi: 10.1038/nature15373 – ident: ref24/cit24 doi: 10.2147/IJN.S423186 – ident: ref23/cit23 doi: 10.1016/j.isci.2022.105147 – ident: ref27/cit27 doi: 10.1016/j.apsb.2017.12.002 |
SSID | ssj0002003189 |
Score | 2.2945104 |
Snippet | Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth... |
SourceID | proquest pubmed crossref acs |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 399 |
SubjectTerms | Angiogenesis Animals Biocompatible Materials - chemistry Biocompatible Materials - pharmacology Blood Platelets - chemistry Cell Movement - drug effects Cell Proliferation - drug effects Hepatocyte Growth Factor - chemistry Hepatocyte Growth Factor - pharmacology Hindlimb - blood supply Hindlimb - drug effects Humans Ischemia - drug therapy Male Materials Testing Nanoparticles - chemistry Neovascularization, Physiologic - drug effects Particle Size Polylactic Acid-Polyglycolic Acid Copolymer - chemistry Polylactic Acid-Polyglycolic Acid Copolymer - pharmacology Rats Rats, Sprague-Dawley Surface Properties |
Title | Platelet Membrane-Coated HGF-PLGA Nanoparticles Promote Therapeutic Angiogenesis and Tissue Perfusion Recovery in Ischemic Hindlimbs |
URI | http://dx.doi.org/10.1021/acsabm.4c01373 https://www.ncbi.nlm.nih.gov/pubmed/39723905 https://www.proquest.com/docview/3149540551 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LbxMxELZKuMChQHmlLxkViZPDrr3ex3EVkaQIqpVIpNxWfqKIZFN1k0N77g9n7N2kpVVErytr5PWMPd9njz8j9DnhcZJBaibackEiY0IiQ5MQqwArM0kB1Hm1z4t4NIm-T_n0br_j4Qk-Db8KVQu56EXKieOxZ-g5jdPE0ay8_2u7m0J9cDqs6wA0AVBNNwqNj0y4PKTqf_PQDnDpk8zgVaN4VHttQldb8qe3Xsmeunms3Pjf_r9G-y3SxHkTGm_QnqkO0Mt7-oNv0W0xB6gJnsM_zQJoc2VIfwlfNB4NB6T4McwxrL5Aq9vqOVz44j2Dx3e3tnAOFpe_3ZI5q7GoNB57X-LCXNm124vDjuLCjLnGswqfA5t29fh4NKv0fLaQ9Ts0GXwb90ekfZaBCMaCFVBXWEEFpTZNIx0EOtQ6jA3NYsM5VRb-U0YBo4YbnQHa1FFmUxEF1koZqkwJ9h51qmVlPiJsmTJBalzpChC7lEqqGQ9kwoXNwHrcRWcwfGU7rerSn5jTsGzGtGzHtIvIxpWlapXN3QMb853tv2zbXzaaHjtbftpERgnTzp2lgCuW67pkjlkC2OVhF31oQmZri7mX3LKAHz6p90foBXVXKnxR4THqrK7W5gSAzkqe-hj_C5Rw-GU |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV1Lb9NAEB6VcgAOlDdpeSwCxGmDvfY69oFDFEgdmlaRSKXeXO-riprYVZ2oKmf-B3-Fn8bsxk55KBKXSlxXq9FqZ2bnm93ZbwDedHjUSTA0U2V4TkOtfSp83aFGIlYOBENQ59g-D6L0MPx8xI824HvzFwYXUaGkyj3iX7EL-O9xLBezdigtR17TrXpPX15gjlZ9GHxEhb5lrP9p3Etp3UaA5piszzHVQo_PGTNxHCrPU75SfqRZEmnOmTQoUIRewDTXKkF0pMLExHnoGSOELxOZByj3BtxE5MNsdtftfVld4jDnExZiW9xOEcuzhhjyryXb8Cer38PfGkzrYlt_C36sdsWVtJy2F3PRll__IIz8j7ftHtytcTXpLh3hPmzo4gHc-YVt8SF8G00RWKOdkn09ExijNe2VOKJIutuno-Ful2CsKc-aWkEycqWKmoyv_qiRLkosT2yAmFQkLxQZO8slI31uFvbmkdiEHs-HSzIpyKCSjpCBpJNCTSczUT2Cw2vZhsewWZSFfgrEBFJ7sbaFOpjGxkwwFXBPdHhuEpQeteA1qiurD5Eqc_UBzM-WOsxqHbaANhaUyZrH3bYTma6d_241_2zJYLJ25qvGIDM8ZOzLEaqiXFRZYPNohPbcb8GTpaWuZAW2b13i8e1_Wv1LuJWO94fZcHCwtwO3me2m7Pl4Vj-Dzfn5Qj9HiDcXL5ybETi-bgP9CZW4Wxk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV1Lj9MwEB4ti4TgwPtRnkaAOLnETpwmBw5Vl27LLqtIdKW9hfiFKtqk2rRCy5l_wl_hhzF2k_JSJS4rcbWskeWZ8Xxjj78BeN4TcS_F0Ey1FQWNjGFUMtOjViFWDiVHUOfZPo_i0XH09kSc7MC39i8MLqJGSbV_xHdevdC2YRhgr3C8kPNupBxPXtux-sCcfcY8rX493kOlvuB8-GYyGNGmlQAtMGFfYrqFXl9wbpMk0kGgmdYsNjyNjRBcWRQooyDkRhidIkLSUWqTIgqslZKpVBUhyr0AF90bocvw-oP3m4sc7v3CwWyH3Snied6SQ_61ZBcCVf17CNyCa318G16D75ud8WUtn7qrpeyqL3-QRv7nW3cdrjb4mvTXDnEDdkx5E678wrp4C75mMwTYaK_knZlLjNWGDioc0WS0P6TZ4X6fYMypFm3NIMl8yaIhk59_1UgfJVYfXaCY1qQoNZl4CyaZObUrdwNJXGKP58QZmZZkXCtPzEBG01LPpnNZ34bjc9mGO7BbVqW5B8SGygSJcQU7mM4mXHIdikD2RGFTlB534BmqK28Okzr3dQKc5Wsd5o0OO0BbK8pVw-fu2orMts5_uZm_WDOZbJ35tDXKHA8b94KEqqhWdR66fBohvmAduLu21o2s0PWvSwNx_59W_wQuZXvD_HB8dPAALnPXVDlgeGQ_hN3l6co8QqS3lI-9pxH4cN72-QMCoV2c |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Platelet+Membrane-Coated+HGF-PLGA+Nanoparticles+Promote+Therapeutic+Angiogenesis+and+Tissue+Perfusion+Recovery+in+Ischemic+Hindlimbs&rft.jtitle=ACS+applied+bio+materials&rft.au=Wang%2C+Peng&rft.au=Di%2C+Xiao&rft.au=Li%2C+Fengshi&rft.au=Rong%2C+Zhihua&rft.date=2025-01-20&rft.issn=2576-6422&rft.eissn=2576-6422&rft.volume=8&rft.issue=1&rft.spage=399&rft.epage=409&rft_id=info:doi/10.1021%2Facsabm.4c01373&rft.externalDBID=n%2Fa&rft.externalDocID=10_1021_acsabm_4c01373 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2576-6422&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2576-6422&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2576-6422&client=summon |